2008
Psoriasis: an opportunity to identify cardiovascular risk
Federman DG, Shelling M, Prodanovich S, Gunderson CG, Kirsner RS. Psoriasis: an opportunity to identify cardiovascular risk. British Journal Of Dermatology 2008, 160: 1-7. PMID: 19016698, DOI: 10.1111/j.1365-2133.2008.08874.x.Peer-Reviewed Original ResearchConceptsCardiovascular risk factorsCardiovascular riskRisk factorsTreatable cardiovascular risk factorsPatients' cardiovascular riskMyocardial infarctionSevere diseaseHealth professionalsPsoriasisPatientsRiskLow qualityAssociationArthritisInfarctionAtherosclerosisInflammationMortalityFactorsPrevalenceDermatologistsDiseaseComplaints
1999
Topical psoriasis therapy.
Federman D, Froelich C, Kirsner R. Topical psoriasis therapy. American Family Physician 1999, 59: 957-62, 964. PMID: 10068717.Peer-Reviewed Original ResearchConceptsTopical therapyTherapeutic armamentariumNew topical therapyPhysician's therapeutic armamentariumLarger patient populationVitamin D analogsTopical retinoidsCommon dermatosesPatient populationD analogsPsoriasisTherapyCorticosteroidsKeratolyticsDermatosesPopulationArmamentariumMainstayRetinoids
1997
Cutaneous clues to systemic disease
Kirsner R, Federman D. Cutaneous clues to systemic disease. Postgraduate Medicine 1997, 101: 137-150. PMID: 9194870, DOI: 10.3810/pgm.1997.06.227.Peer-Reviewed Original Research
1995
Treatment of psoriasis: role of calcipotriene.
Kirsner R, Federman D. Treatment of psoriasis: role of calcipotriene. American Family Physician 1995, 52: 237-40, 243-4. PMID: 7604767.Peer-Reviewed Original ResearchConceptsTopical treatmentMid-potency topical corticosteroidsCareful patient monitoringCommon side effectsNew topical treatmentCommon skin disorderVitamin D derivativesTopical corticosteroidsTopical therapySkin atrophyCalcium metabolismModerate severityCalcipotrieneIrritant dermatitisSide effectsSkin disordersEpidermal cell proliferationKeratolytic agentsD derivativesCell proliferationCorticosteroidsPsoriasisPatient monitoringTreatmentTachyphylaxis